Skip to main content
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1977 Jun;53(3):193–194. doi: 10.1136/sti.53.3.193

Comparison of ornidazole and tinidazole in single-dose treatment of trichomoniasis in women.

L Hillström, L Pettersson, E Pálsson, S O Sandström
PMCID: PMC1045390  PMID: 326349

Abstract

A comparison is made between oral ornidazole in a single 1-5 g dose and tinidazole given in a 2 g dose using a double-blind technique. All the 45 women with Trichomonas vaginalis infection who were treated with ornidazole were cured. In the tinidazole-treated group 41 out of 43 women had negative cultures after treatment. Tolerance was good in both groups.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gaudin G., Chen C. L'emploi du Tibéral dans les vaginites à trichomonas en prise unique. Schweiz Rundsch Med Prax. 1976 May 18;65(20):626–627. [PubMed] [Google Scholar]
  2. Nygaard B., Kjaersgaard H., Korner B., Jensen R. H. Engangsbehandling med ornidazol (Tiberal) og syv dages behandling med metronidazol (Flagyl) ved vaginal trichomoniasis. En kontrolleret undersøgelse i almen praksis. Ugeskr Laeger. 1977 Feb 28;139(9):524–526. [PubMed] [Google Scholar]
  3. Sköld M., Gnarpe H., Hillström L. Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection. Br J Vener Dis. 1977 Feb;53(1):44–48. doi: 10.1136/sti.53.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES